Clinical Trial Update: Observational Study of Acute Intermittent Porphyria Patients

View source ↗

Summary

The observational study of Acute Intermittent Porphyria patients sponsored by Digna Biotech S.L. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Porphyria

Snippet

Sponsor: Digna Biotech S.L. | Conditions: Acute Intermittent Porphyria | Status: COMPLETED